ProCE Banner Activity

What to Expect When Your Patient Is Starting Immune Checkpoint Inhibitor–Based Therapy: Slides

Slideset Download
Download these slides for an expert survey of key safety and efficacy considerations for multidisciplinary healthcare providers caring for patients starting immune checkpoint inhibitors.

Released: March 23, 2021

Expiration: March 22, 2022

No longer available for credit.

Share

Faculty

Marianne Davies

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut